BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

775 related articles for article (PubMed ID: 6444308)

  • 1. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
    Moutsopoulos HM; Fauci AS
    J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets.
    Sakane T; Steinberg AD; Reeves JP; Green I
    J Clin Invest; 1979 Nov; 64(5):1260-9. PubMed ID: 159312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases.
    Moutsopoulos H; Fye KH; Sawada S; Becker MJ; Goldstein A; Talal N
    Clin Exp Immunol; 1976 Dec; 26(3):563-73. PubMed ID: 795579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte subsets in Sjogren's syndrome: a quantitative analysis using monoclonal antibodies and the fluorescence-activated cell sorter.
    Bakhshi A; Miyasaka N; Kavathas P; Daniels TE; Strand CV; Herzenberg LA; Talal N
    J Clin Lab Immunol; 1983 Feb; 10(2):63-9. PubMed ID: 6601716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
    Kammer GM; Birch RE; Polmar SH
    J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphopenia in Sjögren's syndrome with rheumatoid arthritis: relationship to lymphocytotoxic antibodies, cryoglobulinemia, and impaired mitogen responsiveness.
    Utsinger PD; Yount WJ
    J Rheumatol; 1976 Dec; 3(4):355-66. PubMed ID: 1088165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo CD(+) T-cell cytokine expression from patients with Sjögren's syndrome following in vitro stimulation to induce proliferation.
    Koarada S; Haruta Y; Mitamura M; Morito F; Tada Y; Ohta A; Nagasawa K
    Rheumatology (Oxford); 2006 Apr; 45(4):392-9. PubMed ID: 16287915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of the late stages of mitogen-induced human B cell differentiation by FC gamma receptors (FC gamma R) released from polymorphonuclear neutrophils.
    Bich-Thuy LT; Samarut C; Brochier J; Revillard JP
    J Immunol; 1981 Oct; 127(4):1299-303. PubMed ID: 6456302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.
    Delfraissy JF; Segond P; Galanaud P; Wallon C; Massias P; Dormont J
    J Clin Invest; 1980 Jul; 66(1):141-8. PubMed ID: 6447163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell immunoregulation in patients with inflammatory bowel disease. II. Enhanced suppressor T-cell activity in ulcerative colitis.
    Kramer JK; Depew WT; Szewczuk MR
    J Clin Lab Immunol; 1988 Jan; 25(1):19-27. PubMed ID: 2968458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal T cell regulation of IgG synthesis in systemic lupus erythematosus.
    Nies KM; Stevens RH; Louie JS
    J Clin Lab Immunol; 1980 Sep; 4(2):69-75. PubMed ID: 6449594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.
    Auer IO; Röder A; Fröhlich J
    Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
    Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
    Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reticuloendothelial Fc receptor function in patients with Sjogren's syndrome.
    O'Sullivan MM; Walker DM; Williams BD
    Clin Exp Immunol; 1985 Sep; 61(3):483-8. PubMed ID: 4075586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures of T and B cells by levamisole in vitro and in vivo.
    Hersey P; Ho K; Werkmeister J; Abele U
    Clin Exp Immunol; 1981 Nov; 46(2):340-9. PubMed ID: 6461457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial abnormalities of lymphocyte function in a large Sjögren's syndrome kindred.
    Jabs DA; Arnett FC; Bias WB; Beale MG
    J Rheumatol; 1986 Apr; 13(2):320-6. PubMed ID: 3487648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cell-mediated immunity in patients with Sjogren's syndrome].
    Krejsek J; Slezák R; Kopecký O; Vokurková D; Loudová M; Derner V
    Cas Lek Cesk; 1997 Jan; 136(2):44-7. PubMed ID: 9147852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus.
    Tsokos GC; Magrath IT; Balow JE
    J Immunol; 1983 Oct; 131(4):1797-801. PubMed ID: 6311898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration in T lymphocyte subpopulations in inflammatory bowel disease.
    Victorino RM; Hodgson HJ
    Clin Exp Immunol; 1980 Jul; 41(1):156-65. PubMed ID: 6969150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic suppression of polyclonal immunoglobulin production in normals and patients with systemic lupus erythematosus.
    Clough JD; Krakauer RA; Frank SA; Calabrese LH
    Clin Exp Immunol; 1980 Oct; 42(1):27-32. PubMed ID: 6450653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.